Carbonilla, Samuel Scott .
HRN: 12-91-26 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/11/2023
CEFUROXIME 750MG (VIAL)
09/11/2023
09/17/2023
IVT
750mg
Q8hrs
Baiae
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes